Self-administration of injectable contraception: a systematic review and meta-analysis - PubMed (original) (raw)

Self-administration of injectable contraception: a systematic review and meta-analysis

Caitlin E Kennedy et al. BMJ Glob Health. 2019.

Abstract

Introduction: Depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) may facilitate self-administration and expand contraceptive access. To inform WHO guidelines on self-care interventions, we conducted a systematic review and meta-analysis comparing self-administration versus provider administration of injectable contraception on outcomes of pregnancy, side effects/adverse events, contraceptive uptake, contraceptive continuation, self-efficacy/empowerment and social harms.

Methods: We searched PubMed, Cumulative Index to Nursing and Allied Health Literature, LILACS and EMBASE in September 2018 for peer-reviewed studies comparing women who received injectable contraception with the option of self-administration with women who received provider-administered injectable contraception on at least one outcome of interest. Risk of bias was assessed using the Cochrane tool for randomised controlled trials (RCTs) and the Evidence Project tool for non-randomised studies. Meta-analysis was conducted using random-effects models to generate pooled estimates of relative risk (RR).

Results: Six studies with 3851 total participants met the inclusion criteria: three RCTs and three controlled cohort studies. All studies examined self-injection of DMPA-SC; comparison groups were either provider-administered DMPA-SC or provider-administered intramuscular DMPA. All studies followed women through 12 months of contraceptive coverage and measured (dis)continuation of injectable contraception. Meta-analysis found higher rates of continuation with self-administration compared with provider administration in three RCTs (RR: 1.27, 95% CI 1.16 to 1.39) and three controlled cohort studies (RR: 1.18, 95% CI 1.10 to 1.26). Four studies reported pregnancies; all showed no difference across study arms. Four studies reported side effects/adverse events; while two controlled cohort studies showed increased injection site reactions with self-administration, no other side effects increased with self-administration. One study found no difference in social harms. No studies reported measuring uptake or self-efficacy/empowerment.

Conclusion: A growing evidence base suggests that self-administration of DMPA-SC can equal or improve contraceptive continuation rates compared with provider administration. This benefit comes without notable increases in pregnancy or safety concerns. Self-injection of DMPA-SC is a promising approach to increasing contraceptive use.

Keywords: DMPA; injectable contraceptive; meta-analysis; self-administration; systematic review.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1

Figure 1

PRISMA flow chart showing disposition of citations through the search and screening process. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

Figure 2

Figure 2

Meta-analysis of contraceptive continuation: results from randomised controlled trials.

Figure 3

Figure 3

Meta-analysis of contraceptive continuation: results from observational studies.

Comment in

Similar articles

Cited by

References

    1. Brady M. Women’s self-care: a new take on an old practice. Seattle, Washington: PATH, 2018.
    1. Murray M, Brady M, Drake JK. Women's self-care: products and practices. Seattle, Washington: PATH, 2017.
    1. Dragoman MV, Gaffield ME. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): a systematic review. Contraception 2016;94:202–15. 10.1016/j.contraception.2016.02.003 - DOI - PubMed
    1. Jain J, Jakimiuk AJ, Bode FR, et al. . Contraceptive efficacy and safety of DMPA-SC. Contraception 2004;70:269–75. 10.1016/j.contraception.2004.06.011 - DOI - PubMed
    1. Kohn JE, Simons HR, Della Badia L, et al. . Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled Trial at planned parenthood. Contraception 2018;97:198–204. 10.1016/j.contraception.2017.11.009 - DOI - PubMed

Publication types

LinkOut - more resources